{"count": 20, "results": [{"_id": "31751298", "pmid": 31751298, "title": "Could metformin be therapeutically useful in Huntington's disease?", "journal": "Rev Neurosci", "authors": ["Tang BL"], "date": "2020-04-28T00:00:00Z", "doi": "10.1515/revneuro-2019-0072", "meta_date_publication": "2020 Apr 28", "meta_volume": "31", "meta_issue": "3", "meta_pages": "297-317", "score": 50280.79, "text_hl": "Could @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ be therapeutically useful in @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@?", "citations": {"NLM": "Tang BL. Could metformin be therapeutically useful in Huntington's disease? Rev Neurosci. 2020 Apr 28;31(3):297-317. PMID: 31751298", "BibTeX": "@article{31751298, title={Could metformin be therapeutically useful in Huntington's disease?}, author={Tang BL}, journal={Rev Neurosci}, volume={31}, number={3}, pages={297-317}}"}}, {"_id": "35367225", "pmid": 35367225, "title": "Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.", "journal": "Mech Ageing Dev", "authors": ["Trujillo-Del Río C", "Tortajada-Pérez J", "Gómez-Escribano AP", "Casterá F", "Peiró C", "Millán JM", "Herrero MJ", "Vázquez-Manrique RP"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.mad.2022.111670", "meta_date_publication": "2022 Jun", "meta_volume": "204", "meta_issue": "", "meta_pages": "111670", "score": 50266.484, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ to treat @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington disease@@@: A pleiotropic drug against a multi-system @DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities @DISEASE_MESH:D009358 @@@disorder@@@.", "citations": {"NLM": "Trujillo-Del Río C, Tortajada-Pérez J, Gómez-Escribano AP, Casterá F, Peiró C, Millán JM, Herrero MJ, Vázquez-Manrique RP. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. Mech Ageing Dev. 2022 Jun;204():111670. PMID: 35367225", "BibTeX": "@article{35367225, title={Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.}, author={Trujillo-Del Río C and Tortajada-Pérez J and Gómez-Escribano AP and Casterá F and Peiró C and Millán JM and Herrero MJ and Vázquez-Manrique RP}, journal={Mech Ageing Dev}, volume={204}, pages={111670}}"}}, {"_id": "33020379", "pmid": 33020379, "pmcid": "PMC7601223", "title": "Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons", "journal": "Brain Sci", "authors": ["Chen WB", "Chen J", "Liu ZY", "Luo B", "Zhou T", "Fei EK"], "date": "2020-10-04T00:00:00Z", "doi": "10.3390/brainsci10100706", "meta_date_publication": "2020 Oct 4", "meta_volume": "10", "meta_issue": "10", "meta_pages": "", "score": 50260.145, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons", "citations": {"NLM": "Chen WB, Chen J, Liu ZY, Luo B, Zhou T, Fei EK. Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons Brain Sci. 2020 Oct 4;10(10):. PMID: 33020379", "BibTeX": "@article{33020379, title={Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons}, author={Chen WB and Chen J and Liu ZY and Luo B and Zhou T and Fei EK}, journal={Brain Sci}, volume={10}, number={10}}"}}, {"_id": "37397787", "pmid": 37397787, "pmcid": "PMC10312383", "title": "Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes", "journal": "Drug Des Devel Ther", "authors": ["Dutta S", "Shah RB", "Singhal S", "Dutta SB", "Bansal S", "Sinha S", "Haque M"], "date": "2023-06-26T00:00:00Z", "doi": "10.2147/DDDT.S409373", "meta_date_publication": "2023", "meta_volume": "17", "meta_issue": "", "meta_pages": "1907-1932", "score": 50260.01, "text_hl": "Evidence shows that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ crosses the blood-brain barrier to enter the brain and confers diverse neuroprotective effects which can prove beneficial in @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive impairment@@@, @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@ (@<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@), @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@, and probably @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@.", "citations": {"NLM": "Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes Drug Des Devel Ther. 2023;17():1907-1932. PMID: 37397787", "BibTeX": "@article{37397787, title={Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes}, author={Dutta S and Shah RB and Singhal S and Dutta SB and Bansal S and Sinha S and Haque M}, journal={Drug Des Devel Ther}, volume={17}, pages={1907-1932}}"}}, {"_id": "40283923", "pmid": 40283923, "title": "Overview of Metformin and Neurodegeneration: A Comprehensive Review.", "journal": "Pharmaceuticals (Basel)", "authors": ["Kruczkowska W", "Gałęziewska J", "Buczek P", "Płuciennik E", "Kciuk M", "Śliwińska A"], "date": "2025-03-28T00:00:00Z", "doi": "10.3390/ph18040486", "meta_date_publication": "2025 Mar 28", "meta_volume": "18", "meta_issue": "4", "meta_pages": "", "score": 50256.77, "text_hl": "Originally used as a first-line treatment for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, recent studies have begun investigating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s effects beyond @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic disorders@@@, particularly its neuroprotective capabilities against conditions like @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@, and @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@multiple sclerosis@@@. ", "citations": {"NLM": "Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A. Overview of Metformin and Neurodegeneration: A Comprehensive Review. Pharmaceuticals (Basel). 2025 Mar 28;18(4):. PMID: 40283923", "BibTeX": "@article{40283923, title={Overview of Metformin and Neurodegeneration: A Comprehensive Review.}, author={Kruczkowska W and Gałęziewska J and Buczek P and Płuciennik E and Kciuk M and Śliwińska A}, journal={Pharmaceuticals (Basel)}, volume={18}, number={4}}"}}, {"_id": "40003898", "pmid": 40003898, "title": "Endothelial Dysfunction in Huntington's Disease: Pathophysiology and Therapeutic Implications.", "journal": "Int J Mol Sci", "authors": ["Hu N", "Chen Z", "Zhao X", "Peng X", "Wu Y", "Yang K", "Sun T"], "date": "2025-02-08T00:00:00Z", "doi": "10.3390/ijms26041432", "meta_date_publication": "2025 Feb 8", "meta_volume": "26", "meta_issue": "4", "meta_pages": "", "score": 50252.71, "text_hl": "Various therapeutic approaches targeting @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@, including antioxidants, @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@ enhancers, calcium channel blockers, statins, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, have shown promise in preclinical @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@ models but face translational challenges, particularly regarding optimal timing of intervention and @SPECIES_9606 @@@patient@@@ stratification. ", "citations": {"NLM": "Hu N, Chen Z, Zhao X, Peng X, Wu Y, Yang K, Sun T. Endothelial Dysfunction in Huntington's Disease: Pathophysiology and Therapeutic Implications. Int J Mol Sci. 2025 Feb 8;26(4):. PMID: 40003898", "BibTeX": "@article{40003898, title={Endothelial Dysfunction in Huntington's Disease: Pathophysiology and Therapeutic Implications.}, author={Hu N and Chen Z and Zhao X and Peng X and Wu Y and Yang K and Sun T}, journal={Int J Mol Sci}, volume={26}, number={4}}"}}, {"_id": "31874705", "pmid": 31874705, "title": "Metformin reduces prion infection in neuronal cells by enhancing autophagy.", "journal": "Biochem Biophys Res Commun", "authors": ["Abdelaziz DH", "Thapa S", "Abdulrahman B", "Vankuppeveld L", "Schatzl HM"], "date": "2020-03-05T00:00:00Z", "doi": "10.1016/j.bbrc.2019.12.074", "meta_date_publication": "2020 Mar 5", "meta_volume": "523", "meta_issue": "2", "meta_pages": "423-428", "score": 50250.51, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was reported to be beneficial in various @DISEASE_Proteostasis_Deficiencies @DISEASE_MESH:D057165 @@@protein misfolding@@@ and @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative diseases@@@ like @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Alzheimer's and Huntington's diseases@@@. ", "citations": {"NLM": "Abdelaziz DH, Thapa S, Abdulrahman B, Vankuppeveld L, Schatzl HM. Metformin reduces prion infection in neuronal cells by enhancing autophagy. Biochem Biophys Res Commun. 2020 Mar 5;523(2):423-428. PMID: 31874705", "BibTeX": "@article{31874705, title={Metformin reduces prion infection in neuronal cells by enhancing autophagy.}, author={Abdelaziz DH and Thapa S and Abdulrahman B and Vankuppeveld L and Schatzl HM}, journal={Biochem Biophys Res Commun}, volume={523}, number={2}, pages={423-428}}"}}, {"_id": "33161784", "pmid": 33161784, "pmcid": "PMC9482886", "title": "Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system", "journal": "Expert Rev Neurother", "authors": ["Demaré S", "Kothari A", "Calcutt NA", "Fernyhough P"], "date": "2021-01-01T00:00:00Z", "doi": "10.1080/14737175.2021.1847645", "meta_date_publication": "2021 Jan", "meta_volume": "21", "meta_issue": "1", "meta_pages": "45-63", "score": 50247.457, "text_hl": "In a cohort study consisting of 4325 @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@ @SPECIES_9606 @@@patients@@@, 121 of them were using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D.@@@ @SPECIES_9606 @@@Patients@@@ using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ performed significantly better in cognitive and executive functioning tasks compared to @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@ @SPECIES_9606 @@@patients@@@ not receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Demaré S, Kothari A, Calcutt NA, Fernyhough P. Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system Expert Rev Neurother. 2021 Jan;21(1):45-63. PMID: 33161784", "BibTeX": "@article{33161784, title={Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system}, author={Demaré S and Kothari A and Calcutt NA and Fernyhough P}, journal={Expert Rev Neurother}, volume={21}, number={1}, pages={45-63}}"}}, {"_id": "35095535", "pmid": 35095535, "pmcid": "PMC8795875", "title": "The Effects of Combined Therapy With Metformin and Hydroxypropyl-beta-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1", "journal": "Front Pharmacol", "authors": ["Du J", "Liu X", "Zhang Y", "Han X", "Ma C", "Liu Y", "Guan L", "Qiao L", "Lin J"], "date": "2022-01-14T00:00:00Z", "doi": "10.3389/fphar.2021.825425", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "825425", "score": 50245.996, "text_hl": "Recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has proven protective in a wide variety of animal models of @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative diseases@@@, such as @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, and @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@. ", "citations": {"NLM": "Du J, Liu X, Zhang Y, Han X, Ma C, Liu Y, Guan L, Qiao L, Lin J. The Effects of Combined Therapy With Metformin and Hydroxypropyl-beta-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1 Front Pharmacol. 2021;12():825425. PMID: 35095535", "BibTeX": "@article{35095535, title={The Effects of Combined Therapy With Metformin and Hydroxypropyl-beta-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1}, author={Du J and Liu X and Zhang Y and Han X and Ma C and Liu Y and Guan L and Qiao L and Lin J}, journal={Front Pharmacol}, volume={12}, pages={825425}}"}}, {"_id": "32610099", "pmid": 32610099, "title": "Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.", "journal": "Mech Ageing Dev", "authors": ["Soo SK", "Rudich PD", "Traa A", "Harris-Gauthier N", "Shields HJ", "Van Raamsdonk JM"], "date": "2020-09-01T00:00:00Z", "doi": "10.1016/j.mad.2020.111297", "meta_date_publication": "2020 Sep", "meta_volume": "190", "meta_issue": "", "meta_pages": "111297", "score": 50235.105, "text_hl": "In this review, we examine the effects of five compounds that have been shown to extend longevity (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@rapamycin@@@, @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@, @CHEMICAL_Acetylcysteine @CHEMICAL_MESH:D000111 @@@N-acetyl-l-cysteine@@@, @CHEMICAL_Curcumin @CHEMICAL_MESH:D003474 @@@curcumin@@@) in four of the most common @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative diseases@@@ (@DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@, @DISEASE_Amyotrophic_Lateral_Sclerosis @DISEASE_MESH:D000690 @@@amyotrophic lateral sclerosis@@@). ", "citations": {"NLM": "Soo SK, Rudich PD, Traa A, Harris-Gauthier N, Shields HJ, Van Raamsdonk JM. Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders. Mech Ageing Dev. 2020 Sep;190():111297. PMID: 32610099", "BibTeX": "@article{32610099, title={Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.}, author={Soo SK and Rudich PD and Traa A and Harris-Gauthier N and Shields HJ and Van Raamsdonk JM}, journal={Mech Ageing Dev}, volume={190}, pages={111297}}"}}]}